Ufp Technologies (UFPT) Operating Income Growth (1y) (2011 - 2026)
Ufp Technologies (UFPT) Operating Income Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.95 Bn | 176.66 Bn | 6.27 Bn | -20.56% |
| 2 | Stryker | 128.80 Bn | 125.92 Bn | 3.81 Bn | 11.83% |
| 3 | Medtronic | 108.82 Bn | 99.60 Bn | 6.41 Bn | 30.43% |
| 4 | Boston Scientific | 68.54 Bn | 67.08 Bn | 3.61 Bn | 19.54% |
| 5 | Edwards Lifesciences | 48.37 Bn | 44.70 Bn | 1.29 Bn | 20.97% |
| 6 | Dexcom | 28.41 Bn | 27.30 Bn | 750.30 Mn | 90.95% |
| 7 | GE HealthCare Technologies | 28.33 Bn | 26.04 Bn | 1.98 Bn | -18.12% |
| 8 | Smith & Nephew | 26.96 Bn | 26.38 Bn | - | - |
| 9 | Koninklijke Philips | 25.43 Bn | 22.31 Bn | 2.07 Bn | 74.18% |
| 10 | Ufp Technologies | 1.90 Bn | 1.88 Bn | 44.36 Mn | 1.04% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.04% |
| Dec 31, 2025 | -3.39% |
| Sep 30, 2025 | -5.59% |
| Jun 30, 2025 | 35.53% |
| Mar 31, 2025 | 45.23% |
| Dec 31, 2024 | 74.76% |
| Sep 30, 2024 | 64.60% |
| Jun 30, 2024 | 5.33% |
| Mar 31, 2024 | 24.01% |
| Dec 31, 2023 | 17.11% |
| Sep 30, 2023 | -42.06% |
| Jun 30, 2023 | 39.70% |
| Mar 31, 2023 | 101.90% |
| Dec 31, 2022 | 134.68% |
| Sep 30, 2022 | 411.42% |
| Jun 30, 2022 | 96.54% |
| Mar 31, 2022 | 20.00% |
| Dec 31, 2021 | -6.14% |
| Sep 30, 2021 | 36.30% |
| Jun 30, 2021 | 107.31% |